Synthesis and bioavailability of the endogenous gasomediator hydrogen sulfide (H 2 S) is perturbed in many disease states, including those involving mitochondrial dysfunction. There is intense interest in developing pharmacological agents to generate H 2 S. We have synthesised a novel H 2 S donor molecule coupled to a mitochondria-targeting moiety (triphenylphosphonium; TPP + ) and compared the effectiveness of the compound against a standard non-TPP + containing H 2 S donor (e.g. GYY4137) in the inhibition of oxidative stressinduced endothelial cell death. Our study suggests mitochondria-targeted H 2 S donors are useful pharmacological tools to study the mitochondrial physiology of H 2 S in health and disease.
Introduction
Hydrogen sulfide (H 2 S) is now convincingly established as the third gasotransmitter, 1-3 alongside the more familiar nitric oxide (NO) and carbon monoxide (CO). It is enzymatically produced from amino acids cysteine, homocysteine and cystathionine by two pyridoxal-5'-phosphate-dependent enzymes, namely cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS). [1] [2] [3] A third α-ketoglutarate and cysteine-dependent enzyme, located in the mitochondria of cells, 3-mercaptopyruvate sulfurtransferase 4 has also been proposed to generate H 2 S within the mitochondria 5 .
In the vascular system, H 2 S has been proposed as an endothelium-derived vasodilator and genetic knock-out of CSE in animals results in hypertension 6 and accelerates atherosclerosis 7 . Similarly, decreased H 2 S biosynthesis and/or bioavailability have been observed in various human disease states (and animal disease models) [1] [2] [3] including those with marked mitochondrial and endothelial dysfunction and oxidative stress such as hypertension, diabetes, obesity 8 , preeclampsia 9 and after myocardial infarction 10 . Collectively, these studies have highlighted the therapeutic potential of pharmacological strategies to increase H 2 S bioavailability in these pathologies.
There is extensive evidence for a role of oxidative stress, and the over-production of detrimental oxidants, in the vascular endothelium of several human disease states including diabetes, obesity, hypertension and stroke 11 . Oxidant species such as peroxynitrite, (ONOO -) and hydrogen peroxide (H 2 O 2 ), as well as the products of biomolecule oxidation such as the lipid-derived aldehyde 4hydroxynonenal (4-HNE), are well known to induce endothelial and mitochondrial dysfunction and cell death 11 .
Mitochondria are key intracellular organelles determining cell fate (survival and death) and they are a key source (and target) for detrimental oxidant production within cells 12 . As such, compounds that can 'target' mitochondria and prevent or limit mitochondria-mediated oxidative stress have received considerable attention and lipophilic cations such as triphenylphosphonium (TPP + ) have been extensively used for this purpose 13 . TPP + derivatives are extensively and rapidly taken up by mitochondria in vivo, due to the large negative membrane potential inside the mitochondria (∆ψm), resulting in the high concentration of the TPP +derivatives within the mitochondria 13 . The covalent attachment of the lipophilic TPP + cation has become established as a generic and robust method for selectively delivering small, bioactive molecules to mitochondria in vivo. 13 H 2 S donor compounds such as GYY4137 1 (Fig. 1 ) 14 have been shown to exert prominent vasodilatory activity in vitro 14, 15 and in hypertensive animals in vivo 9, 14, 15 . GYY4137 1 also inhibited inflammatory signalling in in vitro [16] [17] [18] [19] and in vivo models of sepsis 18 , arthritis 20 , pre-eclampsia 9 and atherosclerosis 21 . Furthermore, GYY4137 has also been shown to inhibit oxidative stress-mediated cytotoxicity and loss of mitochondrial function induced by H 2 O 2 , ONOOand 4-HNE 22 . However, GYY4137 is highly water soluble 14 , limiting its cellular permeability, and the above studies have all used high concentrations of GYY4137 (≥100 µM) for anti-inflammatory, vasodilatory, cytoprotective and mitochondrial protective effects to be seen. The need for such high concentrations may further limit its therapeutic potential and alternative strategies for generating potent H 2 S donor molecules would be useful.
Dithiolethiones, such as 2, have been proposed as novel species for H 2 S delivery (reviewed in 23 ) ( Fig. 1 ) and dithiolethione derivatives of non-steroidal anti-inflammatory drugs (e.g. naproxen, diclofenac, indomethacin) have been clearly shown to generate H 2 S in vivo, promote gastro-intestinal blood flow and prevent gastric injury in vivo and exert prominent anti-inflammatory effects with marked additional pharmacological benefit over the parent NSAID alone 23-28 .
Fig. 1
H 2 S donors; GYY4137 1, 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione 2.
Therefore, with the above observations in mind, we have synthesised a TPP + -derivative of dithiolethione 2 to generate a novel mitochondria-targeted H 2 S donor molecule. We have then evaluated its effects in a cellular model of oxidative stress and compared its efficacy with an established standard H 2 S donor, GYY4137 1.
Results

Synthesis
Scheme AP39 3 was prepared in an overall yield of 73% using the twostep process shown in Scheme 1. Phosphonium salt 4 was prepared from 10-bromodecanoic acid 5 and triphenylphosphine under reflux conditions in acetonitrile 33 and coupled, using standard carbodiimide conditions, to 5-(4hydroxyphenyl)-3H-1,2-dithiole-3-thione 2. 26 Final purification of 3 was achieved using flash chromatography on silica gel (eluting with methanol), the product forming a crisp foam (which could be handled as a solid) on removal of the solvent.
2.2
Intracellular generation of H 2 S from AP39 Figure 2 show the generation of H 2 S from AP39 3, detected using two different fluorescence probes selective for sulfide, WSP-1 29,30 and 7-azido-4-methylcoumarin (AzMC) 31, 32 . AP39 induced a concentration-dependent increase in WSP-1 fluorescence, indicative of intracellular H 2 S generation 29 in human cerebral microvascular endothelial cells (hCMEC/D3) ( Fig. 2A ). Furthermore, exposure of B.End3 cells to AP39 3 (100 nM) for 1 hour resulted in an increase in the fluorescence of an alternative H 2 S fluorophore AzMC, with significant co-localisation of the signal to mitochondria (Mitotracker) ( Fig. 2B) 
Cytotoxicity
Preliminary control experiments were conducted to confirm that the addition of up to 5 µM AP39 and 2 mM GYY4137 for 24 h did not induce significant cytotoxicity compared with vehicle controls (alamarBlue®; data not shown). In order to show that the cytoprotective effects were due to AP39 3 and not the constituent parts of the AP39 molecule, cells were incubated with 100 nM of the H 2 S donor moiety (ADT-OH, 2), the phosphonium salt containing the mitochondria-targeting motif 4 individually and in combination, and then exposed the cells to SIN-1, H 2 O 2 or 4-HNE. Neither ADT-OH 2, compound 4 (TPP-decanoate) or a 100 nM each of ADT-OH 2 with 4, induced significant cytoprotection against oxidative stress-mediated cytotoxicity (Figs. 3A-C) confirming that cytoprotection was due to AP39 3.
We next compared the efficacy of AP39 3 against an established H 2 S donor compound GYY4137 1, which has previously been shown to protect human mesenchymal progenitor cells and articular chondrocytes from oxidative stress-mediated toxicity 22 . Figure 3 also shows that when used at the same concentration as AP39 (7 -250nM), GYY4137 1 was not cytoprotective. However, as expected 14-20 significant inhibition of oxidative stress-induced cell death was observed with much higher concentrations (e.g. ≥100 µM) ( Fig. 3D ). From these studies, concentrations of 100 nM AP39 and 100 µM GYY4137 1 were used for subsequent experiments. Figure 4 shows AP39 3 (100 nM) and GYY4137 1 (100 µM) significantly inhibited oxidative stress-induced loss of mitochondrial membrane potential ( Fig. 5A ) and inhibited mitochondrial production of reactive oxygen species, detected using mitosox red ( Fig. 4B ). Incubation of cells with AP39 3 (100 nM) or GYY417 1 (100 µM) alone had no significant effect on mitochondrial membrane potential or mitochondrial oxidant production (data not shown). 
Effects of H 2 S donors on mitochondrial membrane potential (∆ ∆ ∆ ∆Ψ Ψ Ψ Ψm), ATP and mitochondrial oxidant production
General synthetic chemistry methods
Starting materials and reagents were obtained from commercial suppliers (Sigma-Aldrich and Fisher Scientific) and were used without further purification. Infrared spectra were recorded using a Perkin Elmer Spectrum BX FT-IR spectrometer. Only major absorbances are quoted, using the abbreviations: (for intensity) w, weak; m, medium; and s, strong. Samples were prepared as potassium bromide discs. 1 H NMR spectra were recorded at 300 MHz using a Bruker ACF300 spectrometer. Chemical shifts are quoted in ppm relative to tetramethylsilane, the residual solvent peak being used for referencing purposes. Coupling constants are quoted to the nearest 0.5 Hz with peak multiplicities for single resonances being labelled as: s, singlet; d, doublet; t, triplet; m, unresolved multiplet, AA'BB', AA'BB' pattern and br, broad. Where delineation of individual resonances is not possible, the relevant peaks are grouped together (over a chemical shift range) as complex. 31 P NMR spectra were recorded at 121 MHz using a Bruker ACF300 spectrometer with external automatic referencing. 13 C NMR spectra were recorded at 75 MHz using a Bruker ACF300 spectrometer. Chemical shifts are quoted in ppm relative to tetramethylsilane, the solvent peak being used for referencing. Coupling constants are quoted to the nearest 1 Hz with peak multiplicities being labelled using (where appropriate) the abbreviation: d, doublet. Mass spectra were recorded by the EPSRC National Mass Spectrometry Service Centre, Swansea, UK, in positive ion electrospray (ES + ) mode.
Analytical thin layer chromatography was carried out using Merck Kieselgel 60 F 254 , coated on aluminium plates, with visualisation of spots by quenching of u.v. (254 nm) fluorescence or staining with alkaline potassium permanganate solution as appropriate. Silica gel with particle size 40-63 µm was used for flash chromatography. Solvents and reagents were used as supplied commercially by SigmaAldrich and Fisher Scientific without additional purification.
A Büchi R110 Rotovapor was used for the removal of solvents under reduced pressure (ca 15 mmHg).
(10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5yl)phenoxy)decyl)triphenylphosphonium bromide (AP39) 3
A solution of 10-bromodecanoic acid 5 (500 mg, 1.99 mmol) in acetonitrile (5 cm 3 ) was added to a stirred solution of triphenylphosphine (522 mg, 1.99 mmol) in acetonitrile (5 cm 3 ) and the resulting mixture was heated at reflux for 70 h. 23 After cooling to room temperature and evaporation of the solvent in vacuo, the residue was triturated with toluene (2 x 10 cm 3 ) and dissolved in dichloromethane (30 cm 3 ). 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione 23,24 2 (456 mg, 2.02 mmol), N,Ndicyclohexylcarbodiimide (431 mg, 2.09 mmol) and 4dimethylaminopyridine (12 mg, 0.10 mmol) were added and the resulting solution was stirred at room temperature for 22 h before filtering through a cotton wool plug and evaporation of the filtrate in vacuo. A dichloromethane solution of the residue was loaded onto a silica gel flash chromatography column, which was subsequently eluted with ethyl acetate, followed by methanol. The methanol fractions were combined and evaporated in vacuo and a dichloromethane solution of the residue was filtered through a filter paper to remove residual silica gel before evaporation in vacuo to give the title compound 
Morpholin-4-ium-4 methoxyphenyl(morpholino) phospinodithioate (GYY4137)
GYY4137 was synthesised as previously described 14 .
Cell Culture
Human cerebral microvascular endothelial cells (hCMEC/D3) were isolated from human brain and kindly provided by Dr. Pierre-Olivier Couraud, University of Paris Descartes [34] [35] [36] . The bEND.3 mouse microvascular endothelial cell line was purchased from the American Type Culture Collection, (ATTC #CRL-2299, Manassas, VA) 37, 38 .
The vascular endothelium is a prime target for oxidative stress in vivo and loss of endothelial function and cell death are observed in cardiovascular diseases such as atherosclerosis, hypertension and diabetes 39, 40 . Therefore we used these cells as an in vitro model of cellular oxidative stress.
hCMEC/D3 cells were seeded on type I collagen (Sigma, rat tail; dilution 1:30) and cultured in endothelial cell media MV2 (PromoCell; C-22221) with a supplement mix (PromoCell; C-39226) diluted to give fetal bovine serum (2.5%), epidermal growth factor (1.25 ng/ml), basic fibroblast growth factor (2.5 ng/ml), insulin-like growth factor (5 ng/ml), vascular endothelial growth factor 165 (0.125 ng/ml), ascorbate (0.25 µg/ml) and hydrocortisone (0.05 ng/ml). hCMEC/D3 cells constitutively express microvascular endothelial cell makers including von Willebrand factor, CD31 (PECAM-1) and CD105 (endoglin) up to passage 35. Cells used in this current study were between passages 25-34. The commercial bEND.3 mouse microvascular endothelial cell line was cultured as described 37, 38 . Murine bEnd.3 cells were maintained in DMEM containing glucose (1g/l) supplemented with 10% fetal bovine serum (10%), non-essential amino acids, (1%) penicillin (100 IU/ml) and streptomycin (100 µg/ml) at 37 °C in 10% CO 2 .
Detection of hydrogen sulfide in living endothelial cells
Cells were seeded in Lab-Tek II chamber coverglass (Nalgen Nunc International) and incubated overnight at 37 o C and 10% CO 2 humidified incubator. After attachment, the cells were loaded with 7-azido-4-methylcoumarin (AzMC, SIGMA L511455) 30, 31 and MitoTracker Red CMXRos (Invitrogen M7512) fluorogenic dyes at 10 microM and 50 nM final concentration, respectively, for 30 min. Next, 100 nM of AP39 3 was added with fresh media and cells were further incubated for 1 hour, washed twice with PBS containing calcium and magnesium. 50 µl of PBS was then added to each chamber and micro cover glass was attached. The dye's specific fluorescence was visualized under 40x magnification using Nikon eclipse 80i inverted microscope with Photometric CoolSNAP HQ2 camera and NIS-Elements BR 3.10 software. An additional sulfidespecific fluorophore, WSP-1 (Caymen, 11179-5) 29,30 was used to determine intracellular generation of H 2 S. In these experiments, cells were seeded overnight in black 96 well microplates (Nalgen Nunc International) and incubated at 37 o C with 10 µM WSP-1 for 30 min 30 . After this time, cells were washed with pre-warmed phenol-red free culture media and AP39 (10 nM -250 nM) added and WSP-1 fluorescence determined (Ex 465nm , Em 515nm ) using Molecular Devices M2e microplate reader.
Cytotoxicity assays
To induce oxidative stress, hCMEC/D3 cells were exposed to either H 2 O 2 (100 µM), SIN-1 (500 µM) or the lipid aldehyde product of lipid peroxidation in vivo, 4hydroxynonenal (4-HNE; 10 µM) for 24 hours in the presence or absence of H 2 S donors GYY4137 1 (100 µM), AP39 3 (100 nM), ADT-OH 2 (100 nM) or compound 4 (100 nM). After this time cell viability, as an end point for cytotoxicity, was assessed by alamarBlue® assay (AbD Serotec; #BUF012) according to the manufacturer's instructions. Fluorescence was then determined using a Molecular Devices M2e plate reader (fluorescence; Ex 540nm / Em 612nm ) as described. Data are expressed as % of untreated or vehicle treated cells (% viability).
Assessment of mitochondrial membrane potential (∆ψm)
Mitochondrial membrane potential, (∆Ψm) in whole hCMEC/D3 cells were measured by using the fluorescent potentiometric probe tetramethylrhodamine methyl ester (TMRM; Invitrogen). TMRM is a membrane-permeable cationic fluorophore that electrophoretically accumulates in mitochondria in response to their negative potential and decrease of TMRM fluorescence is indicative of ∆Ψm disruption and mitochondrial and cellular toxicity. Cells were incubated with SIN-1 (500 µM), H 2 O 2 (100 µM) or 4-HNE (10 µM) in the presence or absence of H 2 S donors for 18 h and after this time, cells were incubated for 30 min with TMRM (200 nM), washed with warm (37 o C) phosphate buffered saline (pH 7.4) and TMRM fluorescence (Relative Fluorescence Units; RFU) determined by fluorimetry (Ex 548nm / Em 573nm ) 41,42 .
ATP determination
hCMEC/D3 cells were seeded overnight on 24 well plates (Greiner) containing 1.0 ml culture media and treated with the respiratory chain inhibitor rotenone (5 µM), and the oxidants SIN-1 (500 µM), H 2 O 2 (100 µM) or 4-HNE (10 µM) in the presence or absence of AP39 (100 nM) or GYY4137 (100 µM) for 18 hours. After this time, cells were washed twice with ice cold phosphate buffered saline (PBS) and lysed with 100 µl of ice-cold trichloroacetic acid (TCA; 10% w / v ). 5 µl of TCA lysate was then added to 200 µl of arsenite buffer (containing 80 mM MgSO 4 , 10 mM KH 2 PO 4 and 100 mM Na 2 HAsO 4, mixed in a 1:1:1 ratio; pH 7.4) followed by 10 µl firefly lantern extract (containing luciferase; Sigma) 41, 42 . Emitted light was recorded on a GloMax Jr, (Promega) luminescence detector as described. ATP concentrations were determined using a freshly prepared standard curve and samples normalised to cellular protein content using a commercial bicinchoninic acid-based kit (Bio-Rad).
Intracellular oxidant production
hCMEC/D3 cells were treated with oxidants and H 2 S donors (GYY4137 1 100 µM; AP39 3, 100 nM) as described above and the production of mitochondria-derived generation of reactive oxygen species were determined by fluorimetry using the mitochondria-targeted oxidant probe MitoSox red TM (Invitrogen, 5 µM) and fluorescence determined (RFU) Ex 390 / Em 580nm 43 .
Statistical analysis
All graphs are plotted with mean ± SEM. In all cases, the mean values were calculated from data taken from at least six separate experiments, performed on separate days using freshly prepared reagents. Where significance testing was performed, an independent t-test (Student's; two populations) was used; * P < 0.1, **P < 0.05, ***P < 0.01.
Discussion
H 2 S has been proposed as novel cytoprotective mediator 22, [44] [45] [46] .
In isolated mesenchymal progenitor cells RNAi-mediated knockdown of CSE potentiated SIN-1, H 2 O 2 and 4-HNEmediated mitochondrial toxicity, an effect reversed with GYY4137 22 . Genetic knockout of CSE renders endothelial 6 and striatal Q111 47 cells more sensitive to oxidative stress-induced toxicity and blood vessels more prone to atherosclerosis 21 . However, it should be noted that this is not seen in all models. For example, hepatocytes from CSE -/mice exposed to galactosamine/lipopolysaccharide were shown to be more sensitive to oxidative injury than wild type animals 48 , although it is unclear if the effects were mediated by H 2 S since CSE knock out did not significantly decrease plasma or liver H 2 S levels and markedly increased plasma homocysteine levels 48 . Nevertheless, in cell culture experiments, H 2 S / HSgenerated from NaSH (albeit at ≥ 100 µM) has been shown to prevent detrimental cytotoxic effects and oxidative protein modification induced by oxidants such as hydrogen peroxide, superoxide, hypochlorite and peroxynitrite (reviewed in reference 46 ). In neuronal cells, NaSH (≥ 100 µM) also inhibited oxidative stress-mediated cell death after treatment with β-amyloid 49 or the mitochondrial toxin 1-methyl-4-phenylpyridinium (MPP + ) 50 . Furthermore, H 2 S is also reported to inhibit the expression and activity of NAD(P)H oxidase, a key source of extra-mitochondrial oxidant species 51 and it upregulates the expression of the antioxidant enzyme thioredoxin-1 in vascular endothelial cells 52 . However, in each of these studies, the concentrations of H 2 S required for each of these studies are often vastly excessive (typically >1-200 µM) and well beyond that seen in health or extreme pathology. Although the absolute level of free H 2 S gas in the vasculature is not known, the most recent analytical techniques have suggested levels of free H 2 S are in the nM to low µM range, suggesting that many of the above cellular studies using NaSH or Na 2 S may not reflect the endogenous effects of physiologically relevant concentrations of H 2 S found in the vasculature 2 .
We recently showed RNAi-mediated knockdown of CSE rendered mitochondria more sensitive to oxidative stressinduced mitochondrial toxicity, an effect which was overcome by the H 2 S donor GYY4137 1 (albeit ≥100 µM) suggesting that endogenous H 2 S may function to preserve mitochondrial integrity 22 . This is supported by in vivo studies. For example, in a rodent cardiac ischaemiareperfusion model, both Na 2 S infusion and selective cardiac CSE over-expression preserved mitochondrial ultrastructure, preserved ATP generation and respiratory chain function in vivo 45 , possibly via a mitochondrial pathway involving the preservation of Bcl-2 signalling, inhibition of Bax, upregulation of PKC and opening of mitochondrial K ATPchannels 10, 52 .
Collectively, these in vitro and in vivo studies have strongly suggested that mitochondria are key regulatory targets for endogenous and exogenously applied H 2 S suggesting that compounds which deliver H 2 S to mitochondria could be therapeutically useful. To test this hypothesis in vitro, we exposed microvascular endothelial cells to oxidative insult and examined cell viability and mitochondrial toxicity after oxidative insult using a novel mitochondria-targeted TPP +derived dithiolethione (AP39, 3) and a well established but nontargeted H 2 S donor molecule GYY4137 1. Concentrations of GYY4137 (100 µM) were chosen based on Figure 3D and the reported cytoprotective effects reported for this compound in a variety of cellular models [14] [15] [16] [17] [18] [19] [20] [21] . In each assay ( Fig. 3-5 ), AP39 3 significantly inhibited oxidative stress induced toxicity at concentrations more than 1,000-fold lower than that of GYY4137 (e.g. 100 nM AP39 c.f. 100 µM GYY4137). In contrast, incubation of cells with TPP + -decanoate (compound 4) which targets mitochondria, but cannot generate H 2 S or the H 2 S donor moiety ADT-OH alone (e.g. lacking TPP + ), did not prevent oxidant-induced cell death (Figs. 3A-C). Similarly, incubation of cells with compound 4 and ADT-OH 2 together also failed to show cytoprotective effects indicating that the whole AP39 molecule (e.g. mitochondria-targeted H 2 S delivery) was required for cell preservation (Figs 3A-C) . Whilst our study clearly shows inhibition of oxidative stress-induced cellular toxicity and mitochondrial preservation by AP39, it is not possible to determine from these data whether mitochondrial protection was the cause or a consequence of cytoprotection. Nevertheless, TPP --derivatised H 2 S donor compounds such as AP39 may be useful tools in studying mitochondria-H 2 S interactions.
Although further work is required to define the precise biomolecular pathways by which AP39 3 prevents cellular injury, the pathways for endogenous mitochondrial generation of H 2 S have recently been uncovered 5,52-56 . The mitochondrial enzyme 3-MST generates low levels of H 2 S and 3-MST-derived H 2 S concentrations in the nanomolar range were very recently shown to contribute electrons to the Krebs cycle, enhance mitochondrial electron transport and bioenergetics 5 , an effect blocked during oxidative stress 54 but reversed with exogenous H 2 S 54 . Recently, CSE 53 and CBS 54, 55 have been shown to translocate from the cytosol in cells to the mitochondrial matrix in response to hypoxic and calcium stress, to generate H 2 S within the mitochondria, possibly acting as an electron acceptor in the mitochondrial respiratory chain, resulting in increased cellular ATP production and cell preservation [53] [54] [55] [56] . It is possible that these effects were also mediated by AP39-derived H 2 S, contributing to the overall cytoprotective effects of this compound since we observed co-localisation of H 2 S generation with mitochondria ( Fig. 2B ) preservation of ATP levels (Fig.  5B ) and mitochondrial ∆ψm ( Fig. 4A ) and decreased mitochondrial oxidant production (Figs. 4B & 5A). Therefore, it appears that the endogenous enzymes responsible for H 2 S generation are either located within or translocate to the mitochondria in response to cellular stress and mitochondriaderived H 2 S contributes to overall cellular bioenergetics and cellular health. Since mitochondrial production of H 2 S is perturbed by oxidative stress and mitochondrial dysfunction and oxidative stress are key pathological events in several human disease states (including hypertension, stroke, neurodegenerative disease, arthritis, hepatitis etc; reviewed in 1-3 ), it is likely that mitochondrial H 2 S delivery may represent a novel approach to study mitochondrial function in health and disease and potentially reveals a novel therapeutic strategy to treat (or limit) mitochondrial dysfunction in human disease.
Conclusions
Our current study shows that coupling H 2 S generating diothiolethione (AP39) to a moiety well characterised to enable selective targeting of intracellular mitochondria (TPP + ) greatly increased the cytoprotective potency of H 2 S relative to a standard and non-targeted H 2 S donor compound GYY4137. Selective pharmacological manipulation of mitochondrial H 2 S may represent a novel approach to preserve mitochondrial function and prevent oxidative stress-induced cellular injury in vivo.
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